Calculation of half-life of carcinoembryonic antigen after lung tumour resection: a case report

Eur Respir J. 1991 Mar;4(3):374-6.

Abstract

Since little is known about carcinoembryonic antigen (CEA) half-life in humans, we followed changes in CEA levels after curative resection of a small bronchial adenocarcinoma in a 54 yr old man with an unusually high preoperative serum CEA level of 1,199 ng.ml-1. Serum CEA followed a four phase curve with an initial increase, attributed to release of CEA from the tumour, a rapid fall during four days (CEA half-life 3.2 days), a slower exponential decay to normal levels during almost three months (CEA half-life 11 days) and eventually maintenance of normal levels for 14 months. These results are consistent with data from animal experiments and a single report on CEA half-life in humans, but CEA half-life seems longer in man than in animals. This observation also suggests that a very high serum CEA level should not in itself preclude curative surgical resection of a primary bronchogenic carcinoma.

Publication types

  • Case Reports

MeSH terms

  • Adenocarcinoma, Bronchiolo-Alveolar / immunology
  • Adenocarcinoma, Bronchiolo-Alveolar / surgery*
  • Carcinoembryonic Antigen / blood*
  • Half-Life
  • Humans
  • Lung Neoplasms / immunology
  • Lung Neoplasms / surgery*
  • Male
  • Middle Aged

Substances

  • Carcinoembryonic Antigen